-The New York Times Blog On March 23, when students and prominent Indians meet at the Wharton School of the University of Pennsylvania for the India Economic Forum, one person will be conspicuous by his absence: Narendra Modi. The chief minister of Gujarat was invited to join the conference via Skype to discuss Gujarat’s development model, but student organizers of the annual conference withdrew their invitation on Sunday after a few University...

-The Times of India WASHINGTON: For liberal, leftist torchbearers, NaMo is still No Go — even virtual contact is anathema. The man at the center of the agitation resulting in Wharton Business School cancelling the keynote address by Gujarat chief minister Narendra Modi (NaMo for headline writers and tweeple) has a long record of liberal activism, and believes the decision by the alumni enhances the prestige of both the students and the...

-PTI Washington: United States has selected the 23-year-old Delhi gangrape victim for the International Women of Courage Award. The award would be presented posthumously by the First Lady Michelle Obama and the Secretary of State John Kerry, on March 8, an official announcement said yesterday. "For millions of Indian women, her personal ordeal, perseverance to fight for justice, and her family's continued bravery is helping to lift the stigma and vulnerability that drive...

-Live Mint Move may help the Congress renew its appeal to a traditional constituency; Activists raise objections In yet another move that the ruling Congress Party hopes will help renew its appeal to a traditional constituency, the ministry of rural development has indicated it is likely to accept the recommendations of a panel that has suggested the universalization of pensions. The task force headed by Planning Commission member Mihir Shah was set up...

-Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees. The report submitted to the health ministry in November is...